A single letter change in your DNA determines whether your earwax is wet or dry, whether your armpits produce strong body odor, and potentially how your body handles certain medications. The gene responsible, ABCC11, sits on chromosome 16 and encodes a transporter protein that shuttles molecules out of cells in your sweat glands, ear canals, and breast tissue. One variant of this gene (called the G allele) produces a fully functional transporter linked to wet earwax and noticeable underarm odor, while the other variant (the A allele) produces a non-functional version associated with dry earwax and minimal odor. The connections between these seemingly unrelated traits, and the gene’s surprising links to breast cancer risk and chemotherapy resistance, make ABCC11 one of the more fascinating examples of how a tiny genetic change can ripple across multiple body systems.
How One Gene Controls Two Unrelated Traits
Earwax type and underarm odor sound like they belong in completely different conversations, but they share an origin in the same type of gland. Apocrine glands are found in your ear canals, armpits, and around the nipples. Unlike the eccrine sweat glands that cover most of your skin and produce the watery sweat that cools you down, apocrine glands secrete a thicker, oilier fluid into hair follicles. The ABCC11 protein acts as a pump in these glands, moving specific molecules from inside the cell into the fluid that gets secreted.
The critical genetic difference comes down to a single spot in the gene’s DNA, known by its catalog number rs17822931. If you carry at least one copy of the G version at this position, your ABCC11 protein works normally, pumping odor precursor molecules and lipids into your apocrine secretions. That gives you wet, honey-colored earwax and the raw ingredients for underarm smell. If you carry two copies of the A version instead, your body breaks down the ABCC11 protein before it can do its job. The protein gets tagged for destruction and recycled, leaving your apocrine glands unable to secrete those same molecules.1PubMed Central. Interplay of human ABCC11 transporter gene variants with axillary skin microbiome functional genomics The result is dry, flaky earwax and armpits that produce very little odor. The G allele is dominant, so you only need one working copy to get the wet-earwax, stronger-odor package.2PubMed Central. ABCC11 Earwax Trait and Genotype Are Suitable Tools for Introductory Labs to Learn Genetics and Molecular Techniques
Where Body Odor Actually Comes From
Here is the part that surprises most people: apocrine sweat itself is nearly odorless when it leaves the gland. The smell you associate with body odor is produced by bacteria living on your skin, not by the sweat itself.3PubMed. A functional ABCC11 allele is essential in the biochemical formation of human axillary odor When the ABCC11 transporter is functional, it pumps a sulfur-containing compound (a glutathione conjugate) into the secretory vesicles of apocrine glands. That compound travels to the skin surface, where a specific group of bacteria takes it up and converts it into a volatile thiol called 3M3SH, which has a strong, characteristic underarm smell.1PubMed Central. Interplay of human ABCC11 transporter gene variants with axillary skin microbiome functional genomics
People with the non-functional ABCC11 variant never pump those precursor molecules to the surface in the first place. Even though the same species of bacteria live on their skin, the bacteria have nothing to work with. No precursors, no volatile thiols, no strong odor. This is why the connection between earwax type and body odor is so reliable: both traits depend on whether the same transporter protein is present and active in apocrine glands. If you have dry earwax, you almost certainly produce little underarm odor, and vice versa.
A Stark Geographic Split
The distribution of the two ABCC11 variants across the globe is one of the most dramatic geographic patterns in human genetics. The A allele, which causes dry earwax and reduced odor, is nearly absent in African populations and relatively uncommon in Europeans, but it is the dominant variant across East Asia.4Molecular Biology and Evolution. The Impact of Natural Selection on an ABCC11 SNP Determining Earwax Type In many East Asian populations, upward of 80 to 90 percent of people carry two copies of the A allele, meaning dry earwax and minimal body odor are the norm rather than the exception. In most of sub-Saharan Africa, the functional G allele is nearly universal.
Even within a single country, the frequency can vary. A nationwide study of Japanese populations found that the A allele frequency differed across the 47 prefectures, with some regions in central Japan showing the highest frequencies and Okinawa showing the lowest.5Journal of Human Genetics. Japanese map of the earwax gene frequency: a nationwide collaborative study by Super Science High School Consortium These regional differences reflect ancient migration patterns and the mixing of different ancestral populations across the Japanese archipelago.
Why the “Dry” Variant Spread
A genetic variant does not reach near-fixation in large populations by accident. Researchers have investigated whether natural selection drove the spread of the A allele, and the evidence points toward adaptation to cold climates. Analysis across Asian, Native American, and European populations found that the frequency of the dry-earwax allele increases significantly with distance from the equator.4Molecular Biology and Evolution. The Impact of Natural Selection on an ABCC11 SNP Determining Earwax Type This latitudinal pattern was unusual: when researchers tested dozens of other genetic variants as controls, none showed the same consistent correlation with latitude across all three continental groups.
The leading hypothesis is that reduced apocrine secretion provided an advantage in cold, dry environments. Less oily secretion in the ear canal and underarm could have meant less moisture trapped against the skin in freezing conditions, reducing the risk of frostbite or skin damage. Ancient DNA studies from East Asian populations have tracked how the A allele’s frequency changed over thousands of years, confirming that it was subject to positive selection and not just genetic drift.6PubMed Central. Population genetic admixture and evolutionary history in the Shandong Peninsula inferred from integrative modern and ancient genomic resources Other factors correlated with latitude, such as sunlight exposure or differences in skin microbiome composition, have not been ruled out as contributing pressures, but the cold-adaptation explanation currently has the strongest support.
Deodorant Use and Cultural Mismatch
One of the more entertaining findings in this field comes from a study of deodorant habits. Researchers found that earwax type and underarm odor are so tightly linked to the ABCC11 genotype that the gene essentially predicts whether a person needs deodorant.7PubMed Central. Dependence of deodorant usage on ABCC11 genotype: scope for personalized genetics in personal hygiene Among people homozygous for the A allele, meaning they produce virtually no precursor compounds for underarm bacteria to work with, a substantial fraction still used deodorant regularly. The researchers described this as a case where social norms around hygiene products had outpaced the underlying biology. People who genetically produce almost no body odor were buying and applying deodorant they did not need, likely because the cultural expectation to use it was so strong.
In East Asian countries where the vast majority of the population carries the dry-earwax genotype, deodorant has historically been a niche product rather than a bathroom staple. The reverse is true in much of Africa, Europe, and the Americas, where the functional G allele predominates and underarm odor is a universal experience. This cultural difference sometimes catches travelers off guard, but it has a straightforward genetic explanation.
The Connection to Breast Tissue
Apocrine glands are not limited to ears and armpits. They also exist in breast tissue, and the ABCC11 transporter is active there too. This means the gene influences more than just earwax and body odor. In a study of Japanese women, those with the dry-earwax genotype produced significantly less colostrum, the thick early milk that the breast produces around the time of childbirth, compared with women carrying the wet-earwax genotype.8PubMed. A strong association between human earwax-type and apocrine colostrum secretion from the mammary gland Among dry-type women, the frequency of having no measurable colostrum at all was significantly higher. The mechanism parallels what happens in the ear and armpit: without a functional ABCC11 transporter, the gland’s secretory output is reduced.
This finding is clinically relevant in a narrow but important way. Postpartum women with dry earwax who struggle with initial milk production may be experiencing a genetically mediated reduction in apocrine secretion, not a problem with their overall lactation ability. Mature breast milk production relies on different glandular mechanisms and is generally unaffected. Awareness of this link could help new mothers and their healthcare providers distinguish between a harmless genetic trait and a breastfeeding difficulty that requires intervention.
ABCC11 and Breast Cancer Risk
Because ABCC11 is expressed in breast tissue and actively transports molecules out of breast cells, researchers have investigated whether the gene variant affects breast cancer risk. A Japanese study found that carrying the functional G allele was associated with a higher odds of breast cancer, with an estimated odds ratio of about 1.63.9PubMed. Association between breast cancer risk and the wild-type allele of human ABC transporter ABCC11 The proposed mechanism involves the transporter’s ability to efflux steroid hormones and other signaling molecules; a fully functional pump might alter the hormonal environment inside breast cells in ways that promote tumor growth.
However, when European researchers tested the same association in women of European descent, they found no link between the ABCC11 genotype and breast cancer risk.10PubMed. The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans This is an important disagreement in the literature, and it may reflect genuine population-level differences in how ABCC11 interacts with other genetic and environmental risk factors for breast cancer. In European populations, the A allele is relatively uncommon, so the comparison groups are very different from those in Japanese studies. The breast cancer connection remains an active area of research, but for now, your earwax type alone should not be treated as a meaningful predictor of breast cancer risk.
Drug Resistance and Pharmacology
The same pump function that moves odor precursors and lipids also gives ABCC11 the ability to move drugs. The functional version of the transporter can push certain chemotherapy agents out of cancer cells, which is exactly the opposite of what oncologists want. Research has shown that ABCC11 confers resistance to 5-fluorouracil (5-FU), a widely used cancer drug, by pumping its active metabolite out of cells before it can do damage.11PubMed. MRP8/ABCC11 directly confers resistance to 5-fluorouracil The gene has also been linked to resistance against methotrexate, another common chemotherapy drug.
The wild-type ABCC11 protein functions as a broad efflux pump for a range of molecules, including cyclic nucleotides and several nucleoside-based anticancer drugs.12PubMed Central. Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failure When a tumor expresses high levels of functional ABCC11, it can potentially shield itself from drugs that would otherwise kill the cancer cells. People carrying the loss-of-function A/A genotype have degraded ABCC11 protein, so their tumor cells might be less able to pump out these drugs. In theory, that could mean they respond better to certain chemotherapy regimens, though clinical studies confirming this directly in patients are still limited.
This is the kind of finding that fits into the broader trend of pharmacogenomics, where genetic testing before treatment helps predict which drugs will work best for a given patient. ABCC11 genotyping is not yet part of standard clinical practice for chemotherapy planning, but the groundwork is being laid.
Targeting ABCC11 for Body Odor Treatment
If the functional ABCC11 transporter is what delivers odor precursors to the skin surface, then blocking that transporter should, in theory, reduce body odor at its source. Researchers have pursued this idea with promising early results. In one line of investigation, febuxostat, a drug already approved for treating gout, was found to inhibit ABCC11’s transport activity in a dose-dependent manner in lab experiments, with minimal effects on related transporter proteins.13International Journal of Clinical Medicine. Research Advances in Axillary Osmidrosis This provides proof of concept that targeted ABCC11 inhibition is pharmacologically possible, though clinical trials in humans have not yet been conducted.
A separate research effort screened dozens of plant-derived compounds for ABCC11-inhibiting activity and identified genistein, an isoflavone found in soybeans, as a natural inhibitor of the transporter. Genistein blocked ABCC11-mediated transport in lab assays, and the researchers suggested it could eventually be developed into a non-surgical treatment for people with strong body odor caused by overactive apocrine glands.14PubMed Central. Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11: In Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary Flavonoids These findings are still preclinical, and eating tofu is unlikely to deliver enough genistein to your armpit glands to make a difference. But they point toward a future where body odor could be managed by pharmacologically mimicking what the A/A genotype does naturally.
Earwax as a Diagnostic Window
Earwax is not just a nuisance you clean out of your ears. Because the ceruminous glands in the ear canal are apocrine glands connected to the bloodstream, earwax accumulates a surprisingly rich array of molecules from the body. It contains genetic material, lipids, proteins, hormones, amino acids, and environmental pollutants, all of which reach the ear canal through blood circulation.15PubMed Central. Insights into cerumen and application in diagnostics: past, present and future prospective Researchers have proposed earwax as a non-invasive diagnostic specimen that could reflect both the body’s internal state and long-term exposure to external chemicals, without requiring a blood draw.
This is still mostly a research idea rather than a clinical tool, but the appeal is obvious. A painless swab of earwax could, in principle, reveal information about hormone levels, drug exposure, or environmental contamination. The ABCC11 genotype matters here too: people with wet earwax produce more cerumen with a richer lipid profile, which may trap and retain more biomarkers. People with dry earwax produce less material to sample from. If earwax diagnostics ever become mainstream, your ABCC11 genotype could determine how useful your earwax is as a health indicator.
Axillary Osmidrosis and the Clinical Perspective
In countries where the dry-earwax genotype is the majority, having strong body odor can carry significant social stigma. In Japan, South Korea, and parts of China, axillary osmidrosis (the medical term for excessive underarm odor linked to overactive apocrine glands) is treated as a clinical condition, sometimes covered by health insurance. Surgical treatments range from liposuction of the axillary area to direct excision of apocrine glands, and newer approaches include laser treatment and microwave-based tissue destruction.
The ABCC11 genotype is strongly predictive of who develops axillary osmidrosis. A large Chinese study confirmed that carrying the G allele at rs17822931 was associated with a dramatically increased risk of the condition, and that people with the risk allele were more likely to have wet earwax, a family history of the condition, and an earlier age of onset.16PubMed Central. A missense variant of the ABCC11 gene is associated with Axillary Osmidrosis susceptibility and clinical phenotypes in the Chinese Han Population Genetic testing for the rs17822931 variant has been proposed as a rapid diagnostic tool, allowing clinicians to confirm the genetic basis of a patient’s complaint in under an hour rather than relying solely on subjective smell tests.17PubMed. Earwax, osmidrosis, and breast cancer: why does one SNP (538G>A) in the human ABC transporter ABCC11 gene determine earwax type?
Whether strong body odor qualifies as a medical problem depends heavily on cultural context. In populations where the G allele is nearly universal, body odor is simply a normal human trait managed with soap and deodorant. In populations where the A allele predominates and most people have little odor, carrying the minority G allele can feel like an isolating condition. The biology is the same either way; only the social framing changes.
Checking Your Own ABCC11 Status
You do not need a genetic test to get a strong clue about your ABCC11 genotype. Look at your earwax. If it is wet, sticky, and yellowish-brown, you almost certainly carry at least one functional G allele. If it is dry, crumbly, and grayish, you likely carry two copies of the A allele. The correlation between earwax type and genotype is one of the tightest phenotype-genotype associations in human genetics, making earwax a reliable proxy for something happening at the molecular level.
Direct-to-consumer genetic testing services like 23andMe report on the rs17822931 variant, so if you have genotyping data, you can check directly. Keep in mind that the G allele is dominant: a person with one G and one A allele (heterozygous) will have wet earwax and produce body odor precursors, though possibly at somewhat lower levels than someone with two G copies. Only the A/A genotype produces the dry-earwax, low-odor profile. If your earwax type has genuinely changed over your lifetime, that is more likely due to aging, ear infections, or changes in the ear canal environment than to any genetic shift; your ABCC11 genotype is fixed from birth.